Asia Pharmaceuticals & Healthcare Key Analysis

Tuberculosis Burden Remains High

While prevalence rates can provide much insight on the extent of a disease in a country, the data can be very patchy - particularly in developing countries that do not have the resources to record...

Read article ›
One Step Closer To A Malaria Vaccine

Communicable diseases will remain a significant health burden over the next two decades forcing companies to adopt low-price, high-volume business models as the burden is overwhelmingly concentrated...

Read article ›
Asia Pacific Remains Highly Attractive

Geographic diversification may be a favourable strategy for multinational pharmaceutical companies, but it is vital that firms recognise both the rewards and the risks present in a market, whether...

Read article ›